← Explore

Efficacy of Low-Intensity Transcranial Ultrasound Stimulation in Enhancing Motor Recovery via Modulation of Microglial Polarization, Angiogenesis and Neurogenesis in MCAO Rats

Mingjun He, Peishan Wu, Xiaojing Long, Chao Shi, Xinhan Cao, Xingchen Huang, Yongjie Zhu, Ruli Li, De Meng, Aidong Li, Chunfang Li, Li Luo, Hongmei Wen, Yao Wang

Ultrasound in Medicine & Biology 2025 · 10.1016/j.ultrasmedbio.2025.05.031

rodentstrokebehaviourother mrihistology molecular

Abstract

Objective Low-intensity transcranial ultrasound stimulation (LITUS) is a novel neuromodulation technology characterized by its non-invasive nature, strong penetration, and high spatial resolution, which has been applied in the treatment of neurological diseases. LITUS has demonstrated effectiveness in promoting motor function recovery following stroke; however, the underlying mechanisms remain unclear. Methods A rat model of middle cerebral artery occlusion (MCAO) was established using the suture method, followed by a 6-day LITUS intervention initiated 24 h postmodel creation. The motor function of MCAO rats was evaluated using the open field test, catwalk gait analysis, and beam walking test. Additionally, a 9.4T animal MRI was employed to assess cerebral infarction volume and edema. Molecular biological changes related to microglial polarization, angiogenesis and neurogenesis were evaluated using enzyme-linked immunosorbent assay and immunofluorescence staining. Results LITUS treatment significantly attenuated ischemic brain injury and improved motor dysfunction in MCAO rats. We observed that MCAO induced microglial activation and polarization in the ischemic brain cortex. Conversely, LITUS treatment inhibited microglial activation, suppressed M1 microglial polarization, and enhanced M2 microglial polarization. Furthermore, LITUS treatment promoted angiogenesis and neurogenesis in the brains of MCAO rats. Conclusion LITUS treatment effectively improves motor dysfunction in MCAO rats, potentially through the regulation of microglial polarization and the promotion of angiogenesis and neurogenesis. Therefore, LITUS may represent a promising therapeutic approach for addressing motor recovery associated with ischemic stroke.

Abstract via europepmc.

Speciesrat (Sprague-Dawley)
Subjects10 animals
Sessions per subject6
Randomisedyes
Blindingsingle
Sham / controlno treatment control
Auditory controlnot reported
Readout timingoffline
Anaesthesiaanaesthetised
Readoutsbehaviour, other mri, histology molecular — open field, CatWalk gait, beam walking; 9.4T MRI infarct and edema; ELISA and immunofluorescence for microglial polarization, angiogenesis, neurogenesis
Direction of effectnot assessedLITUS reduced infarct and edema and improved motor function in MCAO rats and shifted microglia from M1 to M2; neuronal excitability was not measured.
Adverse eventsnot reported

Exposures

Exposure 1: MCAO + LITUS

Target: brain — “cranium”
Device: other named manufacturer · GreenValley BrainTech (Shenzhen) Medical Technology Co., Ltd · GVBT-1-A001 ✓

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)1,000✓✓✓
Pulse duration (ms)0.2✓✓✓
Pulse repetition frequency (Hz)not reported⚑
Duty cycle (%)20✓✓✓
Sonication duration (s)1✓✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)930✓✓✓
Free-field Isppa (W/cm²)7.7✓✓✓
Free-field Ispta (W/cm²)0.77✓✓✓
In-situ estimatemeasurementsingle value
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)0.462✓✓✓
Protocol, in the paper’s words

Pulsed 1 MHz, tone burst 200 us, duty cycle 20%, 1-s stimulus repeated every 2 s; 30 min daily for six consecutive days starting 24 h after MCAO.

Consistency checks: intensity pressure inconsistent free field.

Flags from extraction

  • exposures[0].free_field — Pressure and intensity said to be 'measured' at the focus without stating water; placed in free_field on that reading.
  • exposures[0].in_situ.method — Effective Ispta 462 mW/cm2 from hydrophone measurement of 40% attenuation through skulls; recorded as measurement.
  • blinding — Only outcome observers were blinded for imaging quantification; recorded as single.
  • exposures[0].timing.pulse_repetition_frequency_hz — PRF not stated.
  • exposures[0].target.terms — No anatomical target named; transducer coupled to the cranium, focal zone at 8 mm depth.
  • sham_type — MCAO group received no ultrasound and no sham procedure is described; Control group had no surgery.